Log In
BCIQ
Print this Print this
 

SYNB2010 (formerly SYN110)

  Manage Alerts
Collapse Summary General Information
Company Synlogic Inc.
DescriptionMicrobe engineered for the consumption of phenylalanine
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationPhenylketonuria
Indication DetailsTreat phenylketonuria (PKU)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today